ZCMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 35 of 42 cases where ZCMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 83%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ZCMD's RSI Indicator exited the oversold zone, 29 of 35 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 50 cases where ZCMD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZCMD advanced for three days, in 128 of 173 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZCMD as a result. In 110 of 115 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
ZCMD moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ZCMD entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.464) is normal, around the industry mean (4.477). P/E Ratio (-0.017) is within average values for comparable stocks, (13.414). Projected Growth (PEG Ratio) (0.800) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.002) is also within normal values, averaging (6.065).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ZCMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.
ZETA saw its Momentum Indicator move above the 0 level on November 10, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 82 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 59 cases where ZETA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
ZETA moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ZETA crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 88%.
Following a +13.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZETA advanced for three days, in 289 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
ZETA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 219 of 240 cases where ZETA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The 10-day RSI Indicator for ZETA moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 28 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ZETA turned negative on October 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 42 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZETA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. ZETA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 42 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock slightly better than average.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.407) is normal, around the industry mean (16.360). P/E Ratio (0.000) is within average values for comparable stocks, (53.310). Projected Growth (PEG Ratio) (0.771) is also within normal values, averaging (3.696). Dividend Yield (0.000) settles around the average of (0.434) among similar stocks. P/S Ratio (4.600) is also within normal values, averaging (104.492).
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
ZCMD | ||
|---|---|---|
OUTLOOK RATING 1..100 | 81 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 55 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 97 | |
PRICE GROWTH RATING 1..100 | 95 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ZCMD | ZETA | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 83% | 2 days ago 82% |
| Stochastic ODDS (%) | 2 days ago 82% | 2 days ago 88% |
| Momentum ODDS (%) | 7 days ago 90% | 2 days ago 90% |
| MACD ODDS (%) | N/A | 2 days ago 78% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 86% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 87% |
| Advances ODDS (%) | 3 days ago 74% | 2 days ago 87% |
| Declines ODDS (%) | 7 days ago 90% | 10 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 88% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ZCMD’s FA Score shows that 1 FA rating(s) are green while ZETA’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ZCMD’s TA Score shows that 4 TA indicator(s) are bullish while ZETA’s TA Score has 7 bullish TA indicator(s).
ZCMD (@Services to the Health Industry) experienced а -3.01% price change this week, while ZETA (@Computer Communications) price change was +13.24% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +0.67%. For the same industry, the average monthly price growth was +2.59%, and the average quarterly price growth was +28.54%.
The average weekly price growth across all stocks in the @Computer Communications industry was -2.15%. For the same industry, the average monthly price growth was -11.72%, and the average quarterly price growth was -5.23%.
ZETA is expected to report earnings on Mar 02, 2027.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
@Computer Communications (-2.15% weekly)Computer communications industry develops technology that allows computing devices to exchange data with each other using connections/data links between nodes. Common types of computer network include Cloud (IAN), Internet, Wide (WAN, Local (LAN)/Wireless(WLAN) etc. The industry is an ever-more important part of technology, and is set to become even bigger as the Internet of Things (IoT) rapidly forays into the various aspects of our lives. Cisco Systems, Inc., Palo Alto Networks, Inc. and Arista Networks, Inc., Fortinet, Inc. are some of the major computer communications companies.
A.I.dvisor tells us that ZCMD and ZETA have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ZCMD and ZETA's prices will move in lockstep.
| Ticker / NAME | Correlation To ZCMD | 1D Price Change % | ||
|---|---|---|---|---|
| ZCMD | 100% | -3.81% | ||
| ZETA - ZCMD | 22% Poorly correlated | +8.17% | ||
| SOHU - ZCMD | 21% Poorly correlated | -2.61% | ||
| PEGA - ZCMD | 21% Poorly correlated | +1.28% | ||
| XBP - ZCMD | 21% Poorly correlated | -6.38% | ||
| CHKP - ZCMD | 20% Poorly correlated | +0.42% | ||
More | ||||
A.I.dvisor indicates that over the last year, ZETA has been loosely correlated with AI. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ZETA jumps, then AI could also see price increases.
| Ticker / NAME | Correlation To ZETA | 1D Price Change % | ||
|---|---|---|---|---|
| ZETA | 100% | +8.17% | ||
| AI - ZETA | 57% Loosely correlated | -1.33% | ||
| AVPT - ZETA | 54% Loosely correlated | +0.48% | ||
| BOX - ZETA | 53% Loosely correlated | +2.16% | ||
| OKTA - ZETA | 53% Loosely correlated | +0.44% | ||
| RBRK - ZETA | 53% Loosely correlated | -1.69% | ||
More | ||||